Monsanto Company (MON) Given Consensus Rating of “Hold” by Brokerages
Shares of Monsanto Company (NYSE:MON) have been assigned a consensus rating of “Hold” from the sixteen research firms that are presently covering the stock, Marketbeat reports. Eleven research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $124.61.
A number of analysts recently commented on the company. Barclays PLC reiterated an “equal weight” rating and set a $124.00 price objective (up previously from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. BMO Capital Markets restated a “buy” rating and issued a $128.00 price target on shares of Monsanto in a report on Thursday, October 5th. Macquarie cut Monsanto from an “outperform” rating to a “neutral” rating in a report on Wednesday, October 4th. Wells Fargo & Company lifted their price target on Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a report on Tuesday, October 10th. Finally, Jefferies Group LLC restated a “hold” rating and issued a $128.00 price target on shares of Monsanto in a report on Friday, September 15th.
Monsanto (NYSE:MON) last posted its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.61. The firm had revenue of $2.69 billion during the quarter, compared to analysts’ expectations of $2.51 billion. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The firm’s quarterly revenue was up 4.8% compared to the same quarter last year. During the same quarter last year, the business posted $0.07 EPS.
In other news, CFO Pierre Courduroux sold 4,320 shares of the business’s stock in a transaction that occurred on Thursday, October 19th. The stock was sold at an average price of $122.00, for a total value of $527,040.00. Following the completion of the sale, the chief financial officer now directly owns 48,388 shares in the company, valued at approximately $5,903,336. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Steven Mizell sold 11,526 shares of the business’s stock in a transaction that occurred on Monday, October 9th. The shares were sold at an average price of $119.70, for a total value of $1,379,662.20. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 49,236 shares of company stock worth $5,931,934. 0.79% of the stock is currently owned by corporate insiders.
Several hedge funds and other institutional investors have recently modified their holdings of MON. Boston Private Wealth LLC increased its holdings in shares of Monsanto by 6.6% in the 1st quarter. Boston Private Wealth LLC now owns 4,820 shares of the basic materials company’s stock valued at $546,000 after acquiring an additional 300 shares during the last quarter. HRT Financial LLC bought a new stake in shares of Monsanto in the 1st quarter valued at approximately $488,000. Traynor Capital Management Inc. increased its holdings in shares of Monsanto by 19.8% in the 1st quarter. Traynor Capital Management Inc. now owns 4,543 shares of the basic materials company’s stock valued at $531,000 after acquiring an additional 752 shares during the last quarter. Covington Investment Advisors Inc. increased its holdings in shares of Monsanto by 2.5% in the 1st quarter. Covington Investment Advisors Inc. now owns 20,425 shares of the basic materials company’s stock valued at $2,312,000 after acquiring an additional 490 shares during the last quarter. Finally, Municipal Employees Retirement System of Michigan increased its holdings in shares of Monsanto by 1.1% in the 1st quarter. Municipal Employees Retirement System of Michigan now owns 14,130 shares of the basic materials company’s stock valued at $1,600,000 after acquiring an additional 160 shares during the last quarter. Institutional investors and hedge funds own 74.70% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece of content was originally posted by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/11/02/monsanto-company-mon-given-consensus-rating-of-hold-by-brokerages.html.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.